News
Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press Release
See all News
Burrill State-of-the-Industry Report
June 19, 2012Location: 2012 BIO International Convention
Boston, Massachussetts, United States
G. Steven Burrill, CEO of Burrill & Company, a global financial services firm serving the life sciences industry, discusses themes from his new annual report, Biotech 2012: Innovating in the New Austerity. For 26 years, Mr. Burrill’s reports have helped people understand developments in the biotech industry and where it is heading. Governments worldwide are facing new pressures to contain healthcare spending and demands to develop reliable and environmentally sustainable sources of food, energy, and industrial products. Learn what innovation looks like in 2012, the role it will play in addressing global problems, and how companies will fund it going forward.
Time: 2:00 PM - 3:30 PM
Room: 210ABC
back to Events list